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ackground: Biofilm formation in indwelling medical devices poses serious risk of infection and increases 
the likelihood of  recurrence of infections. The study was carried out to identify the microbes which form 
biofilms on medical implants and are thus involved in nosocomial infections, to assess the potential of 
biofilm producing ability of these isolated microbes and to determine antibiotic resistance towards ampicillin, 
vancomycin ceftazidime, streptomycin and tetracycline.  
Methods: For this, 11 samples of 5 different implants were taken from Tertiary Care Hospital Multan, Pakistan. 
Bacteria were isolated and identified by culture plate method. Tryptone soy broth (TBS) media was used for 
biofilm development by microbes in plastic tubes. Developed biofilm in tubes was visualized with crystal violet 
staining method and then biofilm forming potential was estimated by measuring the optical density through 
spectrophotometer. Antibiotic susceptibility was done by Kirby Bauer disk diffusion method to determine the 
resistance and susceptibility pattern of biofilm producers.  
Results: Out of 11 different samples of indwelling medical devices, a total of 131 bacterial strains were isolated. 
The percentage of bacterial isolates which produced biofilms were Staphylococcus spp. (41%) followed by 
Escherichia coli (18%), Pseudomonas spp. (4%), Proteus spp. (7.2%), Klebsiella spp. (8.6%), Bacillus spp. 
(8.6%), Fusobacterium spp. (1.4%) Clostridium spp.(1.4%), Enterococcus spp. (7.2%) and Neisseria spp. 
(1.4%). Sixty-nine isolates were considered positive for biofilm formation while 58 were considered negative. 
The resistance was maximum against ampicillin (42%) followed by ceftazidime (17.1%), tetracycline (34%) and 
streptomycin (30%) while against vancomycin no resistance was observed.  
Conclusion: Biofilms produced on medical implants by different bacteria are considered to be the major cause 
of hospital acquired infections and are very difficult to eradicate. These biofilms associated implant infections 
are challenging to treat because of their resistance towards various antibiotic therapies. Therefore, some efficient 
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Biofilms are defined as an aggregate of microorganisms 
in which the microbial cells attach irreversibly to each 
other or to living or non-living surfaces to form self-
organized communities. The cells in these complex 
communities are embedded in an adhesive matrix made 
up of the extracellular polymeric substances (EPS) that 
are produced by the cells in the community [1].The EPS 
matrix is an insoluble and oily secretion composed of 
polysaccharides, proteins and nucleic acids [2]. This 
matrix encapsulates the cells residing in a biofilm, alters 
their phenotype by changing growth rates, gene 
regulation and therefore enables them to withstand 
harsh environmental conditions by seizing and 
captivating nutrients from the environment [3]. EPS also 
prevents the incorporation of antimicrobial drugs and 
increases microbial tolerance against drugs [4]. 
Microbes living in a biofilm have adopted several 
modifications with which they have become more 
resistant [5]. They  have altered their phenotype and 
have modified their enzymatic activity and have acquired 
a mutated genotype that includes more resistant genes 
which makes them resistant to antimicrobials [6]. The 
cells in a biofilm communicate with each other with the 
help of different biochemical signals, this cell to cell 
interaction is known as quorum sensing [7]. During 
biofilm formation the attachment of cells to the 
substratum is facilitated by adhesin proteins; formation 
of macro colony and finally dissemination of bacterial 
cells [8].   
Now-a-days medical implants are used in almost every 
health care facility, so a number of medical devices are 
used on daily basis. The bacteria which produce biofilms 
are often opportunistic and often colonize the available 
implants such as urinary catheter, intravascular catheter, 
central venous catheter and endotracheal tube. The 
encrustation of microbes in medical implants may lead to 
nosocomial infection [9]. Nosocomial infections may 
occur repeatedly because these microbes form complex 
colonies and have developed antibiotic resistance. The 
leading cause of nosocomial infection is biofilm formation 
in medical devices. Bacteria producing biofilms on 
medical device surfaces pose great risk of infection to 
the patients using these medical implants. Pathogens 
responsible of nosocomial infection might also come 
from patients own natural flora depending upon the type 
of implant used by the patient. Hospital staff and 
surrounding environment also plays important role in the 
spread of these bacteria [10]. Due to this reason  biofilms 
are associated with 65% of nosocomial infections [11]. 
Indwelling medical devices, such as prosthetics, 
catheters and several other may have helped a lot 
hospital acquired infections, but they still pose a greater 
risk of infection [12]. Certainly, implant colonization 
causes the most recurrent and severe infection 
associated when biomaterial is used. The association of 
the pathogen , biomaterial and the host defense system 
plays important role in implant infection [13]. Host 
immune systems remove the tissue infections caused by 
opportunistic pathogens without generation of an 
immune response by the entry of a foreign body. 
Whereas in implant associated infection an immune 
response is generated by the biomaterial of the implant. 
The infection can be acute and, a foreign body infection 
or tissue granulation. As a result of this  a series of 
immune depression takes place which helps microbes to 
colonize the invasive device and cause infection [14] The 
aims of this research were to characterize common 
bacterial strains contaminating the medical implants, to 
evaluate their potential to produce biofilm and to 
determine antibiotic susceptibility of the isolates. 
Methods 
Sample Collection and Bacterial Characterization 
Different samples of indwelling medical implants (Urinary 
Catheter, Central Venous Catheter, Intravascular 
Catheter Foley’s Urinary Catheter Endotracheal Tubes, 
Stomach Drains and Nasopharyngeal Tube) were 
collected in sterile polythene bags under sterile 
conditions and transported to the lab within 2-3 hours. All 
samples were collected from different wards of Tertiary 
Care Hospital Multan after consent. Samples were 
specifically collected from one week or before from old 
patients who had been catharized and were suffering 
from nosocomial infections during their stay at hospital. 
Approval for this study was obtained from the Ethical 
committee of Nishtar Medical College and Hospital 
Multan, Pakistan. Informed consents were obtained from 
the participants or their guardians before sample 
collection. All medical implants were cut into 2-3 cm long 
and thick discs or tubes and placed in sterile beakers 
filled with phosphate buffer saline (PBS) solution. 
Samples in PBS were stored in refrigerator at 4˚C for 24 
hours. Sample discs or tubes were also placed directly 
on the surface of the culture media and plates were 
placed in incubator at 37˚C for 24 hours. Following 
incubation, the distinct colonies were furthered 
processed on nutrient agar and MacConkey agar and 
biochemically characterized using Bergey's manual of 
systematic bacteriology.  
Biofilm Formation and Quantification 
Tube method (TM) was used to detect microbial biofilm 
production. Three ml tryptone soy broth (TSB) was 
placed in sterile glass tubes. TSB media tubes were 
inoculated with loopful colony of each isolated strain and 
were incubated at 37˚C for 24 hours. After 24 hours, 2 ml 
of 2% glucose was added in each TSB test tube and was 
again incubated for 24 hours at same temperature. After 
total incubation of 48 hours, TSB growth media was 
discarded, and the test tubes were washed thrice 
aseptically with phosphate saline buffer (PBS) of pH 7.4 
to remove any unbound bacteria. After washing with 
PBS, the remaining attached microbes were then fixed 
by using 3 ml of 99% methanol and tubes were left for 15 
minutes. After that, methanol was discarded. The tubes 
were left for drying. In order to observe biofilm production 
by microorganisms, each test tube was stained with 0.3 
ml of 0.1% crystal violet for 5-6 minutes. After 5-6 
minutes, the test tubes were washed carefully with 
running tap water in order to remove the excess stain. 
Once the excess stain was removed, the tubes were left 
to dry by placing them in inverted position. After air drying 
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the tubes dyed adherent cells were solubilized by using 
33% glacial acetic acid. 1.5 ml glacial acetic acid was 
added in each test tube and optical density was 
measured at 570 nm using spectrophotometer. The 
blank for each test tube was phosphate saline buffer PBS 
[10]. 
Antimicrobial Susceptibility Assay 
Purified strains were tested against a panel of 5 
antibiotics namely Ampicillin (10 µg), Ceftazidime (30 
µg), Streptomycin (10 µg), Tetracycline (30 µg) and 
Vancomycin (10 µg) for detection of resistant strains by 
Kirby Bauer disk diffusion method. Diameter of zone of 
inhibition was calculated in millimeters. If the zone of 
inhibition was present around the disc, it showed that 
bacteria were sensitive to tested antibiotic while the 
absence of zone formation showed that the bacteria 
were resistant. The zones were measured and strains 
were categorized according to Clinical and Laboratory 
Standards Institute (CLSI) guidelines [15]. 
Results 
A total of 131 bacterial strains from fifteen different 
samples of indwelling medical implants, were isolated. 
The isolated strains were identified by culture plate 
method, gram staining and biochemical testing system 
according to Bergey’s manual of determinative 
bacteriology as shown in the Figure number 1 and Figure 
2 respectively. 
 
Figure 1: Gram staining  
 
Figure 2: Biochemical Identification of bacterial strains 
 
Figure 3: Percentage of Bacterial Species isolated from Medical 
Implants 
Biofilm Formation 
Out of 131 isolates 69 (52.7%) strains were considered 
biofilm former. Strains were classified as strong, 
moderate and weak biofilm formers based on crystal 
violet stain formation (Figure 3). Quantitative estimation 
of biofilm producer was OD=2×ODc for Weak, moderate 
by 2×ODc≤4×ODc and for strong biofilm former by 
OD≥4×ODc. Isolates from urinary catheters were the 
strongest biofilm producers (58%) while from 
Endotracheal tube weak biofilm formers (50%) were 
observed (table 1). 
Figure 4: Biofilm formation by tube method (A) represents strong 
biofilm formation (B) represents moderate biofilm formation and (C) 
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Urinary Catheter 3 Strong 7(58%) 2.263 
Moderate 3(25%) 1.215 
Weak 2(16%) 0.845 
Intravascular 
Catheter 
2 Strong - - 
Moderate 3(60%) 1.34  
Weak 2(40%) 0.435  
Central venous 
Catheter 
2 Strong 3 (33%) 2.256  
Moderate 6 (66%) 1.345 
Weak - - 
Foleys Catheter 2 Strong 6 (42%) 2.267 
Moderate 7(50%) 1.675  
Weak 1(7.1%) 0.423 
Stomach Drain 1 Strong - - 
Moderate 3(60%) 1.147 
Weak 2(40%) 0.450 
Nasopharyngeal 
Tube 
1 Strong 5(55%) 2.785 
Moderate 3(33%) 1.389 
Weak 1(11%) 0.55 
Yellow Tube 1 Strong 1(25%) 2.680 
Moderate 2(50%) 1.456 
Weak 1(25%) 0.06 
CT Catheter 
Tube 
1 Strong 3(33%) 2.123 
Moderate 3(33%) 1.239 
Weak - - 
Endotracheal 
tube 
2 Strong 3(37.5%) 2.333 
Moderate 1(12.5%) 1.46 
Weak 4(50%) 0.786 
OD: Optical Density 
Table 1: Quantitative estimation and classification of Biofilm formers 
isolated from the different samples. 
Antibiotic Susceptibility Assay 
Antibiotic susceptibility testing was performed on specific 
strains on the basis of the differences in their colony 
morphology, and biochemical testing. Antibiotic testing 
was performed only on those strains which showed 
biofilm production. Percentage of isolates showing 
resistance to ampicillin, streptomycin, tetracycline, 
ceftazidime (figure 5). Vancomycin was susceptible to all 
tested isolates.  
 
Figure 5: Percentage of resistance of biofilm formers against 
antibiotics. 
Discussion 
In this current study samples from urinary catheter, 
central venous catheter, intravascular catheter and 
Foley’s urinary catheter were aseptically collected from 
different wards of Tertiary Care Hospital Multan to 
evaluate tentative biofilm forming microbes colonizing 
these samples. Three samples of urinary catheter were 
collected from patients that were catherized for more 
than 4 days approximately. The catheters from patients 
suffering from urinary tract infections were collected and 
then processed for isolation of biofilm forming bacteria. 
The urinary catheter samples were from 7 days’ old 
admitted patients. All the samples of endotracheal tubes 
were collected from patients who had been on ventilator 
for more than 5 days [16]. The tubes were contaminated 
with biofilm forming bacteria which were main cause of 
ventilator associated pneumonia (VAP) as it was found 
that there is a relationship between colonization of 
endotracheal tube and nosocomial infections [17]. 
Examination of biofilm that was detached from the 
samples was found to harbor groups of microbial 
communities. An assessment of the different bacteria 
that produced the biofilm showed that the 
Staphylococcus spp. (41%) had the highest incidence 
followed by Escherichia coli (18%), Pseudomonas spp. 
(4%), Proteus spp. (7.2%), Klebsiella spp. (8.6%), 
Bacillus spp. (8.6%), Fusobacterium spp. (1.4%), 
Clostridium spp. (1.4%), Enterococcus spp. (7.2%) and 
Neisseria spp. (1.4%) [18]. 
Among all the 69 bacterial strain, 28 (40%) isolates 
were strong biofilm producing bacteria, 32 (46%) were 
moderate and 09 (13%) were weak biofilm producing 
bacteria (Figure 4). Among medical implants urinary 
catheter and Foley’s catheter were highly contaminated 
with Staphylococcus aureus (30%) and Escherichia coli 
(18%) respectively. For detection of biofilms crystal violet 
staining was done. 0.1% crystal violet solution was used 
to stain test tubes for 5 minutes, washed with water and 
dried. On contrary in a study the concentration of CV 
used was 2% for 5 minutes [10]. Optical density at 570 
nm was measured for quantification of biofilm 
production. OD values equal to 2 were considered 
strong, less than 2 but more than 1 were considered 
moderate and OD values less than 1 were considered 
weak. In a similar study optical density values less than 
0.120 were considered weak biofilm producer, 0.120 – 
0.240 was moderate and greater than 0.240 were strong 
biofilm producers. Number of strong, moderate and weak 
biofilm producers was 28, 32 and 09 respectively [19]. 
Similarly in a study 25 strong biofilm producers , 21 
moderate  and 4 weak biofilm producers were isolated 
[20]. In the current study, 15 strains are isolated from 
endotracheal tube (ETT) samples and 8 showed the 
ability of forming biofilm. Mostly the strains isolated were 
species of Staphylococci spp. (62.5%), E.coli (18%) and 
Enterococci spp. (12.5%) which is in good agreement to 
another study where the percentage of endotracheal 
tube contamination was very high, consisting of S. 
epidermidis (37.1%) followed by E. coli (27.1%), K. 
pneumoniae (15.7%), S. aureus (11.4%), E. faecalis 
(4.2%) and P. aeruginosa (4.2%). But contrary to a study 
endotracheal tube was colonized by Acinetobacter, 
Pseudomonas and Klebsiella species. These species 
were dominant bacterial isolates followed by E. coli [21]. 
One sample of ETT did not have any microbe that could 
produce biofilm because the patient from whom the 
sample was taken was given antibiotic treatment. Biofilm 
can be prevented in cases when someone was given a 
systemic digestive decontamination treatment [22]. 
Biofilm formation on endotracheal tubes was associated 
with the presence of airway passage microbes. These 
microbes were able to colonize endotracheal tube and 
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[23]. It was noted that using bacterial filters during 
intubation may prevent thick accumulation of microbes 
and hence may prevent biofilm formation in endotracheal 
tube [24]. Central venous catheters were collected from 
ICU patients. These catheters are made-up of silicone 
tubing and are inserted percutaneously. Catheter 
samples were collected from patients who had been 
catherized for more than 15 days suffering from 
bacteremia and the percentage of contamination with 
microbes was 40%. The microbes isolated from these 
samples were mostly opportunistic flora which indicates 
that the catheter could be contaminated while inserting 
the catheter into the skin i.e. microbes from the body or 
skin colonized the outer layer of catheter and caused 
infection. It was reported that contamination of central 
venous catheter mostly occurs due to skin microflora 
[24].  
The bacterial strains that were isolated in this study 
were mostly found in patients GIT or were normal human 
micro flora. A study reported that these indwelling 
medical plants were mostly colonized by microbes that 
are normal inhabitants of the skin which migrate from the 
skin and accumulate on the outside surface of 
intravascular catheters thereby multiplying on the other 
surface making complex colonies and form biofilms 
[10].These implants colonized by microbes are 
responsible for causing urinary tract infections, ventilator 
associated pneumonia and bloodstream infections etc  
[20]. Development of biofilms on invasive devices is 
usually due to coagulase negative Staphylococci [25]. 
Staphylococci being a member of natural skin flora 
allowed catheters to be colonized by them and provides 
favorable environment for their growth and dissemination 
of infections. In tube method of biofilm formation, out of 
131 bacterial strains only 69 (52%) strains were 
considered as biofilm producers while 62(47%) strains 
were considered non-biofilm producers whereas 76 
biofilm producers and 103 non biofilm formers were 
isolated by tube method in an another study [26]. In this 
study antibiotic susceptibility of the biofilm producers 
was checked [27]. Antibiotic susceptibility testing was 
performed on biofilm producing strains. None of the 
strain showed resistance against vancomycin. However, 
56 strains were resistant against ampicillin, 45 were 
resistant against tetracycline, 40 against streptomycin 
and 02 were against Ceftazidime (Figure 3). Similarly, 80 
% of strains were resistant to ampicillin [28] and no strain 
was resistant vancomycin [20]. In this study, 45 strains 
were resistant against tetracycline whereas in a study 
tetracycline showed resistance to all of the gram positive 
biofilm producing isolates [29]. Due to persistent 
infections the bacterial biofilms are almost resistant to 
conventional antibiotic therapies. This property aids in 
dissemination of resistant genes and characteristics in 
organisms involved in biofilm formation [30]. 
Biofilm formers isolated from medical implants had 
shown resistance towards commonly used antibiotics. 
Therefore, efficient methods for preventing biofilm 
formation on medical implants are needed. 
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